Danon disease, also called glycogen storage disease type IIb, is a metabolic disorder. It is an X-linked lysosomal and glycogen storage disorder, meaning it involves the lysosomes, the cell compartments that break material down, and the storage of glycogen. It is associated with hypertrophic cardiomyopathy, a thickening of the heart muscle, together with skeletal muscle weakness and intellectual disability. The disease is inherited in an X-linked dominant pattern, so a single altered copy of the responsible gene on the X chromosome is enough to be affected. The source lead does not give the name of the gene, the age of onset, or how the condition is managed, so this entry describes classification, main features and inheritance only and leaves further clinical detail for later work.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) First Described Sources
1. Danon disease (Wikipedia)
Lead
It is inherited in an X-linked dominant pattern.
Lead [body-system]
associated with hypertrophic cardiomyopathy, skeletal muscle weakness, and intellectual disability
lead sentence 1
Danon disease (or glycogen storage disease Type IIb) is a metabolic disorder.
Article text
Danon disease was characterized by Moris Danon in 1981.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.